16 / 20
Page 43
conferenceseries
.com
Volume 9
Journal of Clinical & Experimental Ophthalmology
Ophthalmology Conference 2018
September 17-18, 2018
September 17-18, 2018 Tokyo, Japan
17
th
Asia Pacific Ophthalmologists Annual Meeting
J Clin Exp Ophthalmol 2018, Volume 9
DOI: 10.4172/2155-9570-C6-094
Acute choroidal neo-vascular membrane in a 22-year-old patient which was initially assessed with
central serous retinopathy secondary to antidepressant medications
Michel Marco P Figueras
Cardinal Santos Medical Center, Philippines
T
his is a case of a 22-year-old female from the Philippines with a chief complaint of blurring of vision who developed
choroidal neovascular membrane with central retinopathy. The patient had history of anti-psychotropic oral medications
use for 1 year duration (Escitalopram, Quetiapine, Clonazepam and Alprazolam). She was diagnosed with major depressive
disorder 1 year prior and presented on the day of consult with sudden blurring of vision of the left eye. Best corrected vision
was 20/20 on the right eye and 20/70 on the left eye. Fundus exam revealed a surface elevation in the foveal area. Fluorescein
angiography and ocular coherence tomography read as central serous retinopathy. However, further examination after 15 days
on OCT revealed a choroidal neo-vascular membrane developing. Aflibercept injection 0.4 ml was injected once a month for 3
doses. Patient improved to 20/30 on the affected eye thereafter. Central serous choriorioretinopathy is characterized by sudden
unilateral blurring of vision. Histologically, neurosensory detachments and/or retinal pigment detachments can be seen mostly
confined in the macula and is said to have occurred because of leakage of fluid to the sub-retinal spaces. Management includes
careful observation in most cases. However, there is no protocol in management of atypical CSR secondary to anti depressive
medication overdose. We propose that because membranes are irreversible, patients who develop an atypical case of central
serous chorioretinopathy due to antipsychotic drugs need a protocol for monitoring, and if needed, anti VEGF treatment 0.4
ml every month was effective in this case.
marcofigueras@yahoo.com